Recombinant receptors binding B cell activation factor receptor patent
Summary
Recombinant receptors binding B cell activation factor receptor patent
Source document (simplified)
RECOMBINANT RECEPTORS BINDING B CELL ACTIVATION FACTOR RECEPTOR AND USES THEREOF
Publication EP4532534A1 Kind: A1 Mar 18, 2026
Applicants
Seattle Children's Hospital d/b/a Seattle
Children's Research Institute
Inventors
JENSEN, Michael C., JOHNSON, Adam, BAXTER, Blake
IPC Classifications
C07K 14/705 20060101AFI20260209BHEP A61K 35/17 20250101ALI20260209BHEP A61K 47/69 20170101ALI20260209BHEP A61P 35/00 20060101ALI20260209BHEP C12N 15/62 20060101ALI20260209BHEP C12N 15/85 20060101ALI20260209BHEP A61K 48/00 20060101ALI20260209BHEP C07K 16/28 20060101ALI20260209BHEP C12N 5/10 20060101ALI20260209BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.